Canada · Investor

Lumira Ventures

Last cheque observed Jun 2026; 41 cheques on record.

Deploying nowNew fund $30M, May 2026VC firm

SeedSeries ABiotechBiotherapeuticsMedical_devices

Deploying now
100%of best year5cheques in 12 months, 41 on record
Since the last cheque135days00hrs00min00sec
Median round$39MRounds led1 of 41Sole investor3 roundsExits1 from the portfolioMostly inUnited States, 72%
Pitch Lumira Ventures

Lumira Ventures highlights

  1. 01

    5 cheques in the last 12 months

  2. 02

    Mostly Series B and Series C: 49% of its rounds

  3. 03

    Sole investor in 3 rounds, median $11M

  4. 04

    1 exits from the portfolio

What they do

A Leading North American Life Sciences Venture Capital FirmFrom their own website
Type
VC firm (from a list, unverified)
Cheque size
Not stated
Stages
SeedSeries A
Sectors
BiotechBiotherapeuticsMedical_devices
Based in
Toronto, Canada
Cold pitches
Not stated

The record

Every round we can evidence, newest first41 appearances

  1. 2026

    5 rounds

  2. Jun
    COUR PharmaSeries B · US · Lumira Ventures$50MLed
  3. Jun
    ContralineSeries B · Ventureburn$93MWith 9 others
  4. Apr
    Nervonik Inc.Series B · US · Ventureburn$53MWith 6 others
  5. Mar
  6. Jan
    Nocion TherapeuticsSeries B · US · Lumira Ventures$23MWith 9 others
  7. 2024

    3 rounds

  8. Aug
    HistoSonicsSeries D · US · Hatteras Venture Partners$102MWith 7 others
  9. Jun
    EndogenexSeries C · US · Hatteras Venture Partners$88MWith 6 others
  10. Jan
    Cyrano TherapeuticsSeries B · US · Firms' own news pages$9.0MWith 3 others
  11. 2019

    5 rounds

  12. Oct
    AmacaTheraSeed · CA · FinSMEs$3.6MWith 3 others
  13. Oct
    EndotronixSeries D · US · Massdevice$70MWith 8 others
  14. Apr
    Sasuma PharmaceuticalsUS · Biospace$62MWith 9 others
  15. Apr
    Bardy DiagnosticsSeries B · US · FinSMEs$36MWith 8 others
  16. Apr
    HistoSonicsSeries C · US · Hatteras Venture Partners$54MWith 5 others
  17. 2018

    3 rounds

  18. Nov
    Antios TherapeuticsSeries A · US · FinSMEs$25MWith 5 others
  19. Jul
    AntivaSeries C · US · FinSMEs$15MWith 5 others
  20. Apr
    Cardiac DimensionsSeries B · US · FinSMEs$39MWith 6 others
  21. 2017

    1 round

  22. Jan
    Exact ImagingSeries C · CA · FinSMEs$16MWith 1 other
  23. 2016

    1 round

  24. Jul
    EndotronixSeries C · US · FinSMEs$32MWith 2 others
  25. 2015

    9 rounds

  26. Nov
    Social Change RewardsVenture · CA$2.0MWith 3 others
  27. Nov
    BAROnovaSeries D · US$37MWith 4 others
  28. Nov
    First Aid Shot TherapySeries C · US$24MWith 4 others
  29. Jun
    Gladius PharmaceuticalsSeries A · CA$3.3MWith 3 others
  30. Jun
    CeltaxsysSeries D · US$40MWith 4 others
  31. Mar
    Cardiac DimensionsVenture · US$15MWith 4 others
  32. Mar
    Vascular PharmaceuticalsSeries A · US$9.0MSole investor
  33. Feb
    G1 Therapeutics, Inc.Series B · US$33MWith 5 others
  34. Jan
    enGeneSeries B · CA$12MWith 2 others
  35. 2014

    6 rounds

  36. Nov
    Osteopathy QuebecSeed · CAUndisclosedSole investor
  37. Sept
    AvidBiologicsVenture · CAUndisclosedWith 1 other
  38. Jul
    Corvia MedicalSeries D · US$34MWith 3 others
  39. Jun
    Spinal KineticsVenture · US$34MWith 4 others
  40. Apr
    Cardiac DimensionsVenture · US$20MWith 1 other
  41. Feb
    Aurinia PharmaceuticalsCA$52MWith 8 others
  42. 2013

    3 rounds

  43. Aug
    enGeneSeries A · CA · finsmes.com$13MSole investor
  44. Mar
    Corvia MedicalSeries A · US · sec.gov$11MWith 2 others
  45. Feb
    BAROnovaSeries C · US · prnewswire.com$27MWith 5 others
  46. 2012

    3 rounds

  47. Oct
    ThrasosSeries C · CA · businesswire.com$35MWith 6 others
  48. Jun
    U-SystemsGrowth · US · sec.gov$5.0MWith 2 others
  49. Apr
    Argos TherapeuticsSeries D · US · argostherapeutics.com$25MWith 4 others
  50. 2011

    1 round

  51. May
    U-SystemsVenture · US · bizjournals.com$6.5MWith 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration7 named

BRBenjamin RovinskiManaging DirectoriForm ADV
DHDaniel HetuManaging DirectoriForm ADV
GAGerald Albert BrunkManaging DirectoriForm ADV
JJJacki JenuthPrincipal and COOiForm ADV
LHLu HanPrincipaliForm ADV
PVPeter Van Der VeldenManaging General PartneriForm ADV
VLVasco LarcinaCFOiForm ADV

We also hold 19 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$67Mgross assets of its fundsOct 2026
5+funds on filenumbered funds in its name
Exemptreporting adviserventure or small private funds
Legal name
Lumira Capital Investment Management Inc.
SEC number
CRD 164152

Who backs their funds

7 LPs on record in Lumira Ventures's funds

Funds
2

The institutions that put money into its funds, which the firm then invests in companies.Source: fund news.

What they claim to have backed

From their own portfolio page (on their website)

0 of 1 we have independently watched raise

Organiq Media

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

Exits from the portfolio

Companies it backed that were later bought or listed1 in all

U-SystemsBought by GE HealthcareUndisclosedNov 2012

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Lumira Ventures. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies Lumira Ventures put money into.

Quick answers about Lumira Ventures

What does Lumira Ventures invest in?

Lumira Ventures invests most often at Series B and Series C (49% of the rounds on record), in sectors such as Biotech, Biotherapeutics and Medical_devices.

How active is Lumira Ventures?

41 investments on record, 5 of them in the last 12 months, and it led 1. The most recent was in Jun 2026.

What has Lumira Ventures invested in recently?

Its most recent investments on record: COUR Pharma (Series B, Jun 2026), Contraline (Series B, Jun 2026) and Nervonik Inc. (Series B, Apr 2026).

How big are Lumira Ventures's cheques?

The median round it joins is $39M.

Does Lumira Ventures lead rounds?

Sometimes: it led 1 of its 41 investments on record (2%).

Where does Lumira Ventures invest?

Most of the companies it backs are in the United States (72%) and Canada (28%).

Is Lumira Ventures investing now?

Yes: it is actively investing, with 5 investments in the last 12 months.

Who does Lumira Ventures invest alongside?

Most often Arboretum Ventures (3 rounds together), Fonds de solidarite Ftq (3 rounds together) and HealthQuest Capital (3 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it